Nifty
Sensex
:
:
25082.30
82253.46
-67.55 (-0.27%)
-247.01 (-0.30%)

Pharmaceuticals & Drugs

Rating :
44/99

BSE: 524280 | NSE: KOPRAN

179.92
14-Jul-2025
  • Open
  • High
  • Low
  • Previous Close
  •  179
  •  181.88
  •  176.75
  •  178.02
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  135693
  •  24400550.84
  •  369.7
  •  155

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 868.42
  • 22.30
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 990.34
  • 1.67%
  • 1.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.42%
  • 5.87%
  • 42.83%
  • FII
  • DII
  • Others
  • 0.76%
  • 0.00%
  • 6.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.55
  • 11.32
  • 8.78

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.99
  • 9.75
  • -3.14

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.39
  • 19.38
  • -5.83

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.18
  • 18.76
  • 22.95

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.08
  • 2.51
  • 2.17

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.30
  • 12.71
  • 14.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
172.36
186.08
-7.37%
166.24
158.92
4.61%
151.56
152.59
-0.68%
139.44
117.00
19.18%
Expenses
155.28
164.39
-5.54%
146.40
135.34
8.17%
136.82
129.76
5.44%
121.27
110.69
9.56%
EBITDA
17.09
21.69
-21.21%
19.84
23.58
-15.86%
14.74
22.83
-35.44%
18.16
6.31
187.80%
EBIDTM
9.91%
11.66%
11.93%
14.84%
9.72%
14.96%
13.03%
5.39%
Other Income
3.26
9.67
-66.29%
0.17
2.43
-93.00%
0.99
0.13
661.54%
2.63
2.39
10.04%
Interest
2.77
2.59
6.95%
2.16
2.24
-3.57%
2.23
1.94
14.95%
2.18
1.83
19.13%
Depreciation
3.87
3.59
7.80%
4.00
3.27
22.32%
3.85
2.77
38.99%
3.87
3.26
18.71%
PBT
13.71
25.18
-45.55%
13.86
20.51
-32.42%
9.64
18.25
-47.18%
14.73
3.61
308.03%
Tax
4.03
6.56
-38.57%
3.46
4.71
-26.54%
2.26
4.48
-49.55%
3.64
0.84
333.33%
PAT
9.68
18.62
-48.01%
10.39
15.79
-34.20%
7.38
13.77
-46.41%
11.09
2.77
300.36%
PATM
5.61%
10.01%
6.25%
9.94%
4.87%
9.02%
7.96%
2.37%
EPS
2.00
3.86
-48.19%
2.16
3.28
-34.15%
1.53
2.86
-46.50%
2.30
0.58
296.55%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
629.60
614.59
550.99
477.52
491.81
359.50
357.90
313.32
309.72
296.32
325.73
Net Sales Growth
2.44%
11.54%
15.39%
-2.91%
36.80%
0.45%
14.23%
1.16%
4.52%
-9.03%
 
Cost Of Goods Sold
404.61
374.40
334.49
248.55
283.34
192.78
190.88
171.87
164.89
166.92
194.27
Gross Profit
224.99
240.19
216.50
228.97
208.47
166.72
167.02
141.44
144.82
129.39
131.46
GP Margin
35.74%
39.08%
39.29%
47.95%
42.39%
46.38%
46.67%
45.14%
46.76%
43.67%
40.36%
Total Expenditure
559.77
540.23
499.19
390.28
410.20
312.80
312.47
284.27
273.60
266.09
294.29
Power & Fuel Cost
-
24.52
23.16
19.27
16.65
18.08
17.10
14.90
13.71
14.10
12.93
% Of Sales
-
3.99%
4.20%
4.04%
3.39%
5.03%
4.78%
4.76%
4.43%
4.76%
3.97%
Employee Cost
-
52.28
49.95
43.27
37.16
36.85
37.11
32.24
31.37
28.02
28.83
% Of Sales
-
8.51%
9.07%
9.06%
7.56%
10.25%
10.37%
10.29%
10.13%
9.46%
8.85%
Manufacturing Exp.
-
45.34
42.67
38.78
33.89
30.06
32.41
31.35
31.84
27.80
25.56
% Of Sales
-
7.38%
7.74%
8.12%
6.89%
8.36%
9.06%
10.01%
10.28%
9.38%
7.85%
General & Admin Exp.
-
29.56
27.86
28.23
26.35
20.99
18.92
19.20
16.93
15.68
15.38
% Of Sales
-
4.81%
5.06%
5.91%
5.36%
5.84%
5.29%
6.13%
5.47%
5.29%
4.72%
Selling & Distn. Exp.
-
9.40
9.31
8.54
8.42
9.36
9.18
9.56
8.46
9.35
8.16
% Of Sales
-
1.53%
1.69%
1.79%
1.71%
2.60%
2.56%
3.05%
2.73%
3.16%
2.51%
Miscellaneous Exp.
-
4.72
11.77
3.64
4.40
4.69
6.86
5.15
6.39
4.22
8.16
% Of Sales
-
0.77%
2.14%
0.76%
0.89%
1.30%
1.92%
1.64%
2.06%
1.42%
2.82%
EBITDA
69.83
74.36
51.80
87.24
81.61
46.70
45.43
29.05
36.12
30.23
31.44
EBITDA Margin
11.09%
12.10%
9.40%
18.27%
16.59%
12.99%
12.69%
9.27%
11.66%
10.20%
9.65%
Other Income
7.05
14.67
3.06
10.76
18.15
0.63
3.96
10.94
10.66
2.37
6.54
Interest
9.34
8.59
6.08
5.12
6.24
8.91
8.99
8.60
13.70
12.56
12.97
Depreciation
15.59
12.89
12.71
11.10
10.19
9.58
8.74
8.51
8.33
8.12
9.64
PBT
51.94
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
11.91
15.36
Tax
13.39
16.59
8.83
20.75
21.73
7.26
7.64
2.40
4.85
0.00
0.00
Tax Rate
25.78%
24.56%
24.48%
25.37%
26.07%
25.66%
24.13%
10.48%
19.59%
0.00%
0.00%
PAT
38.54
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
10.72
-39.12
PAT before Minority Interest
38.54
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
10.72
-39.12
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.12%
8.29%
4.94%
12.78%
12.53%
5.85%
6.71%
6.54%
6.43%
3.62%
-12.01%
PAT Growth
-24.36%
87.15%
-55.38%
-0.94%
193.10%
-12.49%
17.23%
2.91%
85.73%
-
 
EPS
7.98
10.55
5.64
12.64
12.76
4.35
4.97
4.24
4.12
2.22
-8.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
491.25
439.25
426.17
245.03
189.68
168.48
144.71
124.67
108.72
98.52
Share Capital
48.21
48.21
48.21
43.25
43.25
43.25
43.25
43.25
51.83
49.68
Total Reserves
442.00
391.04
377.96
201.78
146.43
125.23
101.46
81.42
56.89
34.65
Non-Current Liabilities
33.47
33.48
33.13
33.67
40.48
46.17
31.45
32.17
33.00
18.31
Secured Loans
0.45
0.65
0.15
0.33
0.15
0.28
0.44
0.33
0.33
0.63
Unsecured Loans
16.16
17.24
18.62
20.88
31.68
40.84
29.48
32.17
28.36
13.38
Long Term Provisions
9.00
8.51
8.09
7.47
7.20
6.42
5.14
4.59
4.31
4.31
Current Liabilities
218.53
176.97
151.59
160.68
140.05
134.71
135.53
136.49
122.08
158.21
Trade Payables
113.09
87.38
62.30
85.91
54.74
51.16
60.67
47.13
57.04
69.22
Other Current Liabilities
22.80
32.85
31.40
28.85
38.17
35.24
21.30
29.91
26.64
36.70
Short Term Borrowings
81.02
55.51
53.71
43.08
46.23
45.44
52.11
56.09
38.00
51.38
Short Term Provisions
1.63
1.23
4.17
2.84
0.91
2.87
1.45
3.36
0.41
0.90
Total Liabilities
743.25
649.70
610.89
439.38
370.21
349.36
311.69
293.33
263.80
275.04
Net Block
181.71
164.99
150.69
112.19
111.15
112.62
104.44
104.47
100.88
101.56
Gross Block
263.47
233.83
206.81
157.31
146.31
138.14
121.27
112.80
314.06
306.73
Accumulated Depreciation
81.76
68.84
56.12
45.12
35.16
25.52
16.84
8.33
213.18
205.18
Non Current Assets
289.22
250.63
196.01
162.43
147.61
141.79
118.20
113.62
109.78
105.06
Capital Work in Progress
96.59
69.58
35.55
42.89
30.24
24.29
9.93
6.29
3.13
1.23
Non Current Investment
0.06
0.06
0.06
0.05
0.02
0.02
0.05
0.05
0.11
0.11
Long Term Loans & Adv.
9.11
14.33
8.19
6.09
4.90
3.54
2.47
2.30
5.61
2.09
Other Non Current Assets
1.75
1.67
1.53
1.22
1.29
1.32
1.31
0.50
0.03
0.06
Current Assets
454.03
399.07
414.87
276.95
222.60
207.57
193.50
179.72
154.01
169.98
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
138.49
130.61
149.94
100.00
88.50
73.45
71.01
60.56
58.84
45.30
Sundry Debtors
212.33
162.56
127.36
120.08
92.81
86.64
64.77
73.11
56.89
81.17
Cash & Bank
14.20
12.58
57.13
6.90
4.75
3.96
6.18
6.88
4.71
3.73
Other Current Assets
89.02
5.77
4.89
5.83
36.55
43.52
51.54
39.16
33.58
39.78
Short Term Loans & Adv.
43.34
87.55
75.55
44.14
34.26
37.98
47.57
37.33
32.65
38.23
Net Current Assets
235.50
222.10
263.29
116.26
82.55
72.85
57.96
43.23
31.93
11.78
Total Assets
743.25
649.70
610.88
439.38
370.21
349.36
311.70
293.34
263.79
275.04

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
43.26
34.02
-33.48
59.95
31.00
25.41
25.77
15.87
28.63
46.30
PBT
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
10.72
-39.12
Adjustment
20.96
16.29
13.82
16.44
21.63
13.35
13.52
25.15
19.63
76.87
Changes in Working Capital
-30.91
-5.55
-110.81
-23.79
-11.77
-15.72
-7.56
-33.13
-1.71
8.58
Cash after chg. in Working capital
57.59
46.81
-15.21
75.98
38.70
29.30
28.84
16.78
28.64
46.32
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.33
-12.79
-18.27
-16.03
-7.15
-3.88
-3.07
-0.91
-0.01
-0.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-0.55
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-43.55
-12.65
-84.42
-25.28
-12.52
-24.86
-10.96
-17.96
-9.07
-9.62
Net Fixed Assets
-10.46
-5.97
-3.31
-4.35
-4.86
-5.66
-5.43
35.65
-4.54
195.52
Net Investments
-1.20
-0.64
-100.64
-0.65
-0.62
-0.60
-0.32
-0.53
-110.00
-39.20
Others
-31.89
-6.04
19.53
-20.28
-7.04
-18.60
-5.21
-53.08
105.47
-165.94
Cash from Financing Activity
0.99
-19.84
122.82
-34.57
-18.06
-0.58
-15.02
1.97
-19.34
-36.90
Net Cash Inflow / Outflow
0.69
1.53
4.93
0.10
0.42
-0.03
-0.21
-0.12
0.22
-0.22
Opening Cash & Equivalents
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78
0.56
0.79
Closing Cash & Equivalent
8.09
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78
0.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
101.68
91.11
88.40
56.65
43.86
38.95
33.46
28.83
23.15
18.43
ROA
7.32%
4.32%
11.62%
15.22%
5.84%
7.27%
6.77%
7.15%
3.98%
-13.63%
ROE
10.96%
6.29%
18.19%
28.34%
11.74%
15.34%
15.21%
17.71%
12.19%
-43.06%
ROCE
13.78%
8.30%
21.40%
30.40%
13.69%
16.30%
13.88%
19.24%
13.09%
-12.48%
Fixed Asset Turnover
2.47
2.53
2.66
3.30
2.54
2.76
2.69
1.49
0.98
1.11
Receivable days
111.32
94.82
93.20
77.53
90.59
77.21
79.96
74.44
82.54
74.79
Inventory Days
79.90
91.76
94.14
68.65
81.75
73.66
76.30
68.37
62.26
53.60
Payable days
97.72
81.67
108.83
90.60
60.78
68.76
72.54
73.61
89.54
68.97
Cash Conversion Cycle
93.50
104.91
78.51
55.58
111.55
82.11
83.72
69.21
55.25
59.43
Total Debt/Equity
0.20
0.17
0.17
0.27
0.47
0.58
0.61
0.76
0.65
0.92
Interest Cover
8.86
6.93
16.98
14.36
4.17
4.52
3.66
2.81
1.85
-2.02

News Update:


  • USFDA concludes surveillance inspection at API unit of Kopran’s arm
    29th Apr 2025, 15:10 PM

    The inspection was conducted from April 21, 2025 to April 25, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.